USMLE Step 2 CK practice question: Diabetic ketoacidosis with hypokalemia: potassium before insulin

USMLE Step 2 CKEndocrineInternal Medicine

A 24-year-old woman with type 1 diabetes mellitus is brought to the emergency department because of a 2-day history of nausea, vomiting, diffuse abdominal pain, and increasing fatigue. She ran out of insulin 4 days ago and could not afford a refill. Her only medications are insulin glargine and insulin lispro. She does not drink alcohol or use illicit drugs. She appears ill. Temperature is 37.2°C (99.0°F), pulse is 118/min, respirations are 30/min and deep, and blood pressure is 102/64 mm Hg. Mucous membranes are dry. The abdomen is diffusely tender without guarding or rebound. Laboratory studies show: Serum Sodium 131 mEq/L Potassium 2.9 mEq/L Chloride 96 mEq/L Bicarbonate 9 mEq/L Urea nitrogen 28 mg/dL Creatinine 1.3 mg/dL Glucose 486 mg/dL β-Hydroxybutyrate 6.8 mmol/L Arterial blood pH 7.16 ECG shows sinus tachycardia with prominent U waves. An infusion of 0.9% sodium chloride is started at 1 L/h.

Which of the following is the most appropriate next step in management?

  1. Intravenous potassium chloride, with insulin withheld until serum potassium is ≥3.5 mEq/L
  2. Intravenous regular insulin infusion with potassium chloride added to the fluids
  3. Intravenous sodium bicarbonate
  4. Intravenous potassium phosphate
  5. Subcutaneous rapid-acting insulin every 2 hours
Show answer and explanation

Correct answer: A. Intravenous potassium chloride, with insulin withheld until serum potassium is ≥3.5 mEq/L

This patient has diabetic ketoacidosis (DKA) precipitated by insulin omission: hyperglycemia, ketonemia (β-hydroxybutyrate ≥3.0 mmol/L), and a high anion gap metabolic acidosis (anion gap = 131 − [96 + 9] = 26 mEq/L; pH 7.16; bicarbonate 9 mEq/L). Patients with DKA have a large total-body potassium deficit from osmotic diuresis and vomiting, even though serum potassium is usually normal or elevated at presentation because insulin deficiency and hyperosmolality shift potassium out of cells. A low serum potassium at presentation (2.9 mEq/L, with U waves on ECG) therefore signals a profound deficit. Insulin drives potassium into cells and would cause a further, potentially fatal fall in serum potassium (ventricular arrhythmias, cardiac arrest, respiratory muscle weakness).

The 2024 multisociety consensus report on hyperglycemic crises in adults (ADA, EASD, JBDS, AACE, and DTS) recommends continuing IV fluid resuscitation, starting IV potassium replacement with cardiac monitoring, and delaying insulin until serum potassium is ≥3.5 mEq/L. Once potassium is 3.5–5.0 mEq/L, insulin is started (e.g., IV infusion at 0.1 U/kg/h) and potassium is added to the IV fluids to keep serum potassium at about 4–5 mEq/L; if potassium is >5.0 mEq/L, insulin is started without potassium and levels are rechecked frequently. Bicarbonate is considered only for pH <7.0, and phosphate is replaced only for severe hypophosphatemia (<1.0 mg/dL) or related complications.

High-yield summary: in DKA, check potassium before giving insulin — K⁺ <3.5 mEq/L → IV potassium and hold insulin; K⁺ 3.5–5.0 → insulin plus potassium in fluids; K⁺ >5.0 → insulin without potassium, with frequent rechecks.

Why the other options are wrong

  • B. Intravenous regular insulin infusion with potassium chloride added to the fluids — Starting insulin with potassium added to the fluids is appropriate when serum potassium is 3.5–5.0 mEq/L; at 2.9 mEq/L, insulin would worsen hypokalemia and risk a fatal arrhythmia.
  • C. Intravenous sodium bicarbonate — Bicarbonate is considered only for severe acidosis with pH <7.0; it shifts potassium into cells (worsening hypokalemia) and has not been shown to improve outcomes at this pH.
  • D. Intravenous potassium phosphate — Routine phosphate replacement is not recommended in DKA; it is reserved for severe hypophosphatemia (<1.0 mg/dL) or associated complications, and excess phosphate can cause hypocalcemia. Potassium chloride is the appropriate agent for potassium repletion.
  • E. Subcutaneous rapid-acting insulin every 2 hours — Subcutaneous rapid-acting insulin analogs are an option for mild or uncomplicated moderate DKA, but any form of insulin must be withheld until serum potassium is ≥3.5 mEq/L.

Key point

In DKA, serum potassium must be checked before insulin is given; if potassium is <3.5 mEq/L, replace potassium intravenously and withhold insulin until potassium is at least 3.5 mEq/L.

Memory hook

Insulin is a potassium vacuum — it sucks K⁺ into cells. K⁺ <3.5? Replace it first; no insulin until K⁺ ≥3.5, or arrhythmia follows.

Share: Telegram WhatsApp X LinkedIn

Practice like this every day

15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.

Play free

More free questions in this system

MEN 2A: RET proto-oncogene (medullary thyroid carcinoma, pheochromocytoma, hyperparathyroidism)USMLE Step 1 · EndocrineInferior STEMI with right ventricular infarction and hypotensionUSMLE Step 2 CK · CardiovascularEmpiric therapy for community-acquired bacterial meningitis in an adult older than 50 yearsUSMLE Step 2 CK · NervousHepatitis B immunoprophylaxis for a preterm infant of an HBsAg-positive motherUSMLE Step 2 CK · PediatricsDrug-induced hyperkalemia with ECG changes: immediate intravenous calciumUSMLE Step 2 CK · RenalGiant cell arteritis with transient monocular vision loss: IV pulse glucocorticoids before biopsyUSMLE Step 2 CK · Musculoskeletal

All free questions →